Acuta Capital Erasca Bets Big on Targeted Cancer Therapies
A niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
We compare value-focused dividend growth ETFs to help you spot the best option based on cost, yield, and growth potential.
27,266 articlesA niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
Biotech stocks often ride a volatile wave of news, milestones, and insider moves. In the last year, one biotechnology...
Dive into how to read myriad genetics (mygn) 2025 earnings transcripts, spot growth drivers, assess risk, and build a...
As 2025 earnings season unfolds, AvePoint faces a pivotal moment in cloud data governance and SaaS expansion. This gu...
On July 16, the stock market faced pressure as a major space-tech name announced a $1 billion convertible notes offer...
META sits at a pivotal moment. With AI-enabled engagement, ad momentum, and new monetization paths, analysts wonder i...
What a difference a year makes. Last year, Wall Street questioned this AI stock’s valuation. Today, analysts anticipa...
Figma posted impressive numbers in early 2026, yet the stock slumped. This article breaks down the drivers behind fig...
A quiet revolution in AI compute centers around CPUs designed for AI workloads. This article explains why the era of ...
A pop culture moment becomes a practical finance lesson. Discover the money truths behind Carmen Electra’s reflection...
Fantasy Top captivated Crypto Twitter with a fresh take on fantasy sports powered by blockchain. Now, after two years...
A new kind of space stock is building recurring AI-powered intelligence from satellites. This article breaks down the...